Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 55,252 | 682 | 0 | 0 | 0 |
| Cost of Goods | 7,973 | 167 | N/A | N/A | N/A |
| Gross Profit | 47,279 | 515 | N/A | N/A | N/A |
| Operating Expenses | 325,719 | 167,994 | 172,440 | 135,080 | 125,665 |
| Operating Income | -277,467 | -167,312 | -172,440 | -135,080 | -125,665 |
| Interest Expense | 72,009 | 41,968 | 27,305 | 6,788 | 4,581 |
| Other Income | 15,150 | 7,688 | 2,022 | -2,015 | 1,178 |
| Pre-tax Income | -334,326 | -201,592 | -197,723 | -143,883 | -129,068 |
| Net Income Continuous | -334,326 | -201,592 | -197,723 | -143,883 | -129,068 |
| Net Income | $-334,326 | $-201,592 | $-197,723 | $-143,883 | $-129,068 |
| EPS Basic Total Ops | -5.29 | -3.93 | -5.05 | -3.89 | -3.88 |
| EPS Basic Continuous Ops | -5.29 | -3.93 | -5.05 | -3.89 | -3.88 |
| EPS Diluted Total Ops | -5.29 | -3.93 | -5.05 | -3.89 | -3.88 |
| EPS Diluted Continuous Ops | -5.29 | -3.93 | -5.05 | -3.89 | -3.88 |
| EPS Diluted Before Non-Recurring Items | -4.53 | -2.53 | -5.05 | -3.89 | -3.88 |
| EBITDA(a) | $-274,480 | $-164,860 | $-169,710 | $-130,964 | $-124,069 |